Genedx Holdings (WGS) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Genedx Holdings Corp   (NASDAQ: WGS)
 

Genedx Holdings Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Genedx Holdings 's inventory turnover ratio sequentially decreased to 8.84 in the third quarter 2026, unsurprisingly, as the Genedx Holdings markets continue to deteriorate, and WGS's faces growing challenges to bring down its inventories. Genedx Holdings 's average inventory processing period in the Sep 30 2026 quarter, has increased to 41 days, from 36 days, in the Jun 30 2026 quarter.

Within Healthcare sector 32 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 303 in the second quarter 2026, to 366.

WGS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Genedx Holdings Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

WGS Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 105.35 % 49.35 % -3.32 % 31 % -1.87 %
Y / Y Cost of Sales Growth 15.75 % 16.78 % 21.43 % 26.67 % 10.34 %
Inventory Turnover Ratio (TTM) 8.84 10.27 11.09 10.51 10.56
WGS's Total Ranking # 366 # 303 # 295 # 220 #
Average inventory processing period 41 36 33 35 35
Seq. Inventory Growth 21.79 % 45.58 % -12.26 % 32 % -11.42 %
Seq. Cost of Sales Growth 2.32 % 6.48 % -10.53 % 18.75 % 3.23 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 11
Healthcare Sector # 33
Overall Market # 366

Inventory Turnover Ratio Statistics
High Average Low
13.87 9.91 6.28
(Sep 30 2023)   (Sep 30 2022)



WGS Company Profile >> Back to WGS Efficiency Comparisons >> Compare WGS Inventory Turnover Ratio to its Competitors

Financial Statements
Genedx Holdings 's Inventories $ 22 Millions Visit WGS's Balance sheet
Genedx Holdings 's Cost of Revenues TTM $ 145 Millions Visit WGS's Income Statement
What are WGS's Sales? Visit WGS's Sales by Segment

Other Inventory Turnover Ratios
Genedx Holdings 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
WGS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for WGS's Competitors
Inventory Turnover Ratio for WGS's Suppliers
Inventory Turnover Ratio for WGS's Customers

You may also want to know
WGS's Sales Growth Rates WGS's Pe Price to earnings ratio WGS's Receivables Turnover Ratio WGS's Stock Quote
WGS's Net Income Growth Rates WGS's Ps Price to Sales ratio WGS's Sales per Employee WGS's Asset Turnover Ratio
WGS's Net Margin WGS's Pb Price to Book ratio WGS's Financial Strength Ratios WGS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Precipio inc   17.63 $ 15.391  Millions$ 1  Millions
Cryo cell International Inc   16.60 $ 6.680  Millions$ 0  Millions
Alnylam Pharmaceuticals Inc   12.28 $ 1,135.254  Millions$ 92  Millions
Brightspring Health Services Inc   11.57 $ 7,583.638  Millions$ 655  Millions
Tarsus Pharmaceuticals Inc   10.68 $ 49.325  Millions$ 5  Millions
Sotera Health Company  10.25 $ 558.509  Millions$ 54  Millions
Lantheus Holdings Inc   9.76 $ 604.826  Millions$ 62  Millions
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions

Date modified: 2026-11-11T10:22:04+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.